#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crigler-Najjar syndrome Non-Hodgkin's lymphoma unspecified histology indolent Vernal keratoconjunctivitis Oesophageal atresia Cognitive disorder Hodgkin's disease Infantile apnoea Oesophageal carcinoma Osteochondrodysplasia Neuropathic arthropathy Chronic graft versus host disease in liver Aplastic anaemia Neuroendocrine carcinoma of the skin Giant cell tumour of tendon sheath Pyoderma gangrenosum More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Life with Disease Retinoblastoma – Life with Disease Nephroblastoma – Basic Information Retinitis pigmentosa – Life with Disease Fabry’s disease Primary biliary cholangitis Angiosarcoma recurrent – Treatment Hyperoxaluria – Treatment Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Prader-Willi syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluvastatin Sodium Vib1116 Tigecycline Fosfomycin Omp11 Human Coagulation Factor Vii Cetrelimab Metreleptin Tramadol Hydrochloride Anitocabtagene Autoleucel Lactose Ravulizumab Naloxegol Oxalate Felis Domesticus (555) Docetaxel Deucravacitinib Zilucoplan Sodium AZD3632 Vanzacaftor Nofazinlimab More therapies…

    Learn about Your Condition

    Uveitis Anogenital dysplasia Post procedural swelling Allergic respiratory disease Pseudomyxoma peritonei Arteriovenous graft thrombosis Embolic stroke Ocular lymphoma Andersen-Tawil syndrome Complicated appendicitis Upper limb fracture Bipolar disorder Thymoma Haemorrhage Infertility More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Amlodipine
    • Amlodipine Besilate
    • Eplerenone
    Poland

  • Study on Gadobutrol for Patients with Idiopathic Normal Pressure Hydrocephalus to Understand Cerebrospinal Fluid Movement Using MRI

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Flutemetamol (18F)
    • Gadobutrol
    Sweden

  • Study of Pembrolizumab for Patients with High-Risk Thyroid Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on Reducing Side Effects of Lutetium (177Lu) Oxodotreotide in Patients with Advanced Midgut Neuroendocrine Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Small intestine neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    France Spain

  • Study on Sodium Benzoate and Clozapine for Adults with Refractory Schizophrenia Symptoms

    Recruiting

    4 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • SODIUM BENZOATE
    Poland

  • Study on the Effects of Sonelokimab in Patients with Active Psoriatic Arthritis or Axial Spondyloarthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Germany
Previous Page
1 … 238 239 240 241 242 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!